XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 1,587,982 $ 3,237,106
Accounts receivable, net 55,391 261,809
Other current assets 425,024 729,342
Current assets held for sale 64,671 118,459
Total current assets 2,133,068 4,346,716
Other Assets 250,383
Intangible Assets, net 490,242 566,259
Goodwill 4,183,232 4,183,232
Non-current assets held for sale 23,685 27,595
Total assets 6,830,227 9,374,185
Current Liabilities:    
Accounts payable and accrued expenses 1,871,443 1,154,072
Deferred revenue 73,869 81,318
Current liabilities held for sale 17,795 13,759
Total current liabilities 1,963,107 1,249,149
Non-current Liabilities:    
Credit facility, net 458,800
Convertible debt, net 7,983,896 7,841,500
Accrued severance liability 325,000
Total liabilities 10,730,803 9,090,649
Commitments and Contingencies (Note 12)
Stockholders’ (Deficit) Equity:    
Common stock, $0.0001 par value, 250,000,000 shares authorized;25,864,437 and 25,319,095 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 2,587 2,532
Additional paid in capital 141,317,627 140,255,234
Accumulated deficit (145,352,653) (140,130,159)
Accumulated comprehensive income 131,863 155,929
Total stockholders’ (deficit) equity (3,900,576) 283,536
Total liabilities and stockholders’ (deficit) equity $ 6,830,227 $ 9,374,185